| Affiliation: | 1. MayoClinic, Rochester, USA;2. Department of Hematology, National Cancer Centre Hospital, Tokyo, Japan;3. Hematology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy;4. Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Centre, Shizuoka, Japan;5. Division of Clinical Hemato-Oncology, Istituto Europeo di Oncologia, Milan, Italy;6. Department of Clinical Hematology and Diagnostics, Osaka University Graduate School of Medicine, Osaka, Japan;7. Department of Medical Oncology, National Cancer Centre, Beijing;8. Cancer Hospital, Chinese Academy of Medical Sciences, Beijing;9. Peking Union Medical College, Beijing, China;10. Department of Internal Medicine, University Hospital Brno, Brno, Czech Republic;11. Department of Medicine, University of Alabama, Birmingham, USA;12. UAB-CCC, Bone Marrow Transplantation and Cell Therapy Program, University of Alabama, Birmingham, USA;13. Internal Medicine & Hematology, Instituto Nacional de Cancerologia, Bogota, Colombia;14. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China;15. Fourth Department of Internal Medicine—Hematology, University Hospital, Hradec Králové;16. Faculty of Medicine, Hradec Králové, Czech Republic;17. Department of Haematology, CHU Haut-Lévèque, Bordeaux, France;18. Department of Internal Medicine, Hotel Dieu de France University Hospital, Beirut, Lebanon;19. Princess Margaret Cancer Centre, Toronto, Canada;20. Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea;21. CHU de Quebec, Hôpital de l''Enfant Jésus, Quebec City, Canada;22. Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Japan;23. Ankara University Medical Faculty, Ankara, Turkey;24. University of Texas, Houston, USA;25. MD Anderson Cancer Center, Houston, USA;26. Oncology Clinical Development, Novartis Pharmaceuticals Corporation, East Hanover, USA;27. Novartis Pharma, Paris, France;28. Oncology Institute of Southern Switzerland, Bellinzona, Switzerland |
